HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses

AIDS

Volumn 24, Issue 8, 2010, Pages 1095-1105

  Owen, Rachel E ^a,b   Heitman, John W ^a   Hirschkorn, Dale F ^a   Lanteri, Marion C ^a   Biswas, Hope H ^a   Martin, Jeffrey N ^c   Krone, Melissa R ^c   Deeks, Steven G ^c   Norris, Philip J ^d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b Departments of Laboratory Medicine   (United States)

^c Division of Biostatistics and Epidemiology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Activation; Cellular immunity; HIV; Pathogenesis; Regulatory T cells

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHEMOKINESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; VIRAL LOAD;

EID: 77951877224     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283377a1e     Document Type: Article

References (57)

1. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-416.
2. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, et al. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 2009; 83:329-335.
3. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, et al. Relationship between T cell activation and CD4R T cell count in HIV-seropositive individuals with un-detectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197:126-133. (Pubitemid 351263476)
4. Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cyto-toxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104:6776-6781. (Pubitemid 47175577)
5. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79:14169-14178. (Pubitemid 41552715)
6. Almeida M, Cordero M, Almeida J, Orfao A. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1R patients. Cytometry B Clin Cytom 2007; 72:22-33. (Pubitemid 46105454)
7. Benito JM, Lopez M, Lozano S, Ballesteros C, Martinez P, Gonzalez-Lahoz J, Soriano V. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4R T cells under successful highly active anti-retroviral therapy. J Acquir Immune Defic Syndr 2005; 38:373-381. (Pubitemid 40381546)
8. Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL. Selective increase of activation antigens HLA-DR and CD38onCD4R CD45ROR T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95:436-441. (Pubitemid 24210185)
9. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8R T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4R cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92. (Pubitemid 27465572)
10. Eggena MP, BarugahareB, Okello M, Mutyala S, JonesN, Ma Y, et al. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4R T cell depletion, and coinfection. J Infect Dis 2005; 191:694-701. (Pubitemid 40271056)
11. Fernandez S, Price P, McKinnon EJ, Nolan RC, French MA. Low CD4R T-cell counts in HIV patients receiving effective anti-retroviral therapy are associated with CD4R T-cell activation and senescence but not with lower effector memory T-cell function. Clin Immunol 2006; 120:163-170. (Pubitemid 44080682)
12. Kolber MA. CD38RCD8R T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. AIDS 2008; 22:1937-1941.
13. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4RCD25R regulatory T cells. Nat Immunol 2003; 4:330-336.
14. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10:801-805. (Pubitemid 39070850)
15. Sakaguchi S. Naturally arising Foxp3-expressing CD25RCD4R regulatory T cells in immunological tolerance to self and nonself. Nat Immunol 2005; 6:345-352. (Pubitemid 41716771)
16. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4RCD25RTcells regulate virus-specific primary and memory CD8R T cell responses. J Exp Med 2003; 198:889-901.
17. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4RCD25 high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-1253.
18. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4R regulatory T cells express lower levels of the IL-7 receptor alpha chain(CD127), allowingconsistentidentification and sorting of live cells. J Immunol Methods 2007; 319:41-52. (Pubitemid 46110995)
19. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and sup-pressive function of human CD4R Treg cells. J Exp Med 2006; 203:1701-1711. (Pubitemid 44036276)
20. Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM. FOXP3 expressing CD127lo CD4R T cells inversely correlate with CD38R CD8R T cell activation levels in primary HIV-1 infection. J Leukoc Biol 2008; 83:254-262. (Pubitemid 351225605)
21. O'Garra A, Vieira P. Twenty-first century Foxp3. Nat Immunol 2003; 4:304-306. (Pubitemid 36432308)
22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immu-nologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
23. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25(R)CD4(R) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-310. (Pubitemid 30470313)
24. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, et al. HIV-1-driven regulatory T-cell accumulation in lym-phoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-3817. (Pubitemid 44864563)
25. Tenorio AR, Martinson J, Pollard D, Baum L, Landay A. The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J Acquir Immune Defic Syndr 2008; 48:577-580.
26. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, LevyY.Human immunodeficiency virus-driven expansion of CD4RCD25R regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-3256. (Pubitemid 39507143)
27. Baker CA, Clark R, VenturaF, Jones NG, Guzman D, Bangsberg DR, Cao H. Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 2007; 147:533-539. (Pubitemid 46208056)
28. Chase AJ, Sedaghat AR, German JR, Gama L, Zink MC, Clements JE, Siliciano RF. Severe depletion of CD4R CD25R regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J Virol 2007; 81:12748-12757. (Pubitemid 350156912)
29. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174: 4407-4414. (Pubitemid 40396024)
30. Jiang Q, Zhang L, Wang R, Jeffrey J, Washburn ML, Brouwer D, et al. FoxP3RCD4R regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/-mice in vivo. Blood 2008; 112:2858-2868.
31. Jiao Y, Fu J, Xing S, Fu B, Zhang Z, Shi M, et al. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8(R) T cells in HIV-1-infected typical progres-sors, but not in long-term nonprogressors. Immunology 2008; 128 (Suppl 1):e366-e375.
32. Mozos A, Garrido M, Carreras J, Plana M, Diaz A, Alos L, et al. Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients. J Acquir Immune Defic Syndr 2007; 46:529-537. (Pubitemid 350191045)
33. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8:757-762. (Pubitemid 24163417)
34. Fan J, Bass HZ, Fahey JL. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993; 151:5031-5040. (Pubitemid 2009647)
35. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994; 265:248-252. (Pubitemid 24987014)
36. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cyto-kine detection on single cell level by flow cytometry. AIDS 1997; 11:1111-1118. (Pubitemid 27273607)
37. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4R T helper cell depletion occurs. J Clin Invest 1988; 82:1908-1914. (Pubitemid 19054937)
38. Vyakarnam A, Matear P, Meager A, Kelly G, Stanley B, Weller I, Beverley P. Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin Exp Immunol 1991; 84:109-115.
39. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retro-viruses 2006; 22:757-762. (Pubitemid 44735002)
40. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, et al. Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83:3719-3733.
41. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-1700. (Pubitemid 44036275)
42. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8R T cells. Blood 2006; 107:4781-4789. (Pubitemid 43882629)
43. Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA 2008; 105:19851-19856.
44. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8R T cells. PLoS Med 2008; 5:e100. (Pubitemid 351760908)
45. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(R) and CD8(R) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-11991. (Pubitemid 33115870)
46. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, et al. Mucosal immune responses to HIV-1 in elite controllers: A potential correlate of immune control. Blood 2009; 113:3978-3989.
47. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007; 21:1525-1534. (Pubitemid 47075472)
48. Kolte L, Gaardbo JC, Skogstrand K, Ryder LP, Ersboll AK, Nielsen SD. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active antiretroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol 2009; 155:44-52.
49. Gaardbo JC, Nielsen SD, Vedel SJ, Ersboll AK, Harritshoj L, Ryder LP, et al. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of im-munological and virological status, as well as initiation of highly active antiretroviral therapy. Clin Exp Immunol 2008; 154:80-86.
50. Lim AY, Price P, Beilharz MW, French MA. Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4R T cells from HIV-infected patients responding to antiretroviral therapy. Immunol Cell Biol 2006; 84:530-536. (Pubitemid 44657025)
51. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC. The dynamic co-evolution of memory and regulatory CD4R T cells in the periphery. Nat Rev Immunol 2007; 7:231-237. (Pubitemid 46310481)
52. Antons AK, Wang R, Oswald-Richter K, Tseng M, Arendt CW, Kalams SA, Unutmaz D. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J Immunol 2008; 180:764-773.
53. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115:1953-1962. (Pubitemid 40979735)
54. Chase AJ, Yang HC, Zhang H, Blankson JN, Siliciano RF. Preservation of FoxP3R regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4R T-cell activation. J Virol 2008; 82:8307-8315.
55. Kozlowska E, Biernacka M, Ciechomska M, Drela N. Age-related changes in the occurrence and characteristics of thymic CD4(R) CD25(R) T cells in mice. Immunology 2007; 122:445-453. (Pubitemid 47556482)
56. Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, Leyhe T, et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neu-roimmunol 2007; 188:117-127. (Pubitemid 47095016)
57. Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, et al. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol 2009; 130:298-303.